Xavis Co., Ltd. (KOSDAQ:254120)
968.00
+8.00 (0.83%)
At close: Sep 18, 2026
Xavis Revenue
Xavis had revenue of 8.08B KRW in the quarter ending June 30, 2026, a decrease of -10.35%. This brings the company's revenue in the last twelve months to 27.36B, down -2.58% year-over-year. In the year 2025, Xavis had annual revenue of 27.90B, down -25.83%.
Revenue (ttm)
27.36B
Revenue Growth
-2.58%
P/S Ratio
1.09
Revenue / Employee
196.81M
Employees
139
Market Cap
29.73B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.90B | -9.72B | -25.83% |
| Dec 31, 2024 | 37.61B | 8.90B | 31.02% |
| Dec 31, 2023 | 28.71B | 6.39B | 28.61% |
| Dec 31, 2022 | 22.32B | 6.25B | 38.87% |
| Dec 31, 2021 | 16.07B | 3.80B | 30.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PEMTRON | 83.00B |
| Komelon | 77.65B |
| V-One Tech | 62.28B |
| FIBERPRO | 53.60B |
| VC Inc. | 52.30B |
| Senko | 42.33B |
| Xperix | 24.98B |
| Precision Biosensor | 23.66B |